7.82 USD
-0.03 (-0.38%)
Overall FENC gets a fundamental rating of 3 out of 10. We evaluated FENC against 525 industry peers in the Biotechnology industry. FENC may be in some trouble as it scores bad on both profitability and health. FENC is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- FENC had negative earnings in the past year.
- FENC had a negative operating cash flow in the past year.
- In the past 5 years FENC always reported negative net income.
- FENC had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
- FENC has a Return On Assets of -14.09%. This is amongst the best in the industry. FENC outperforms 80.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.09% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-49.57%
ROA(5y)-56.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Gross Margin, with a value of 93.12%, FENC belongs to the top of the industry, outperforming 93.90% of the companies in the same industry.
- The Profit Margin and Operating Margin are not available for FENC so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 93.12% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- Compared to 1 year ago, FENC has more shares outstanding
- Compared to 5 years ago, FENC has more shares outstanding
- Compared to 1 year ago, FENC has an improved debt to assets ratio.
2.2 Solvency
- FENC has an Altman-Z score of -2.03. This is a bad value and indicates that FENC is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -2.03, FENC is in line with its industry, outperforming 51.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.03 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 4.69 indicates that FENC has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 4.69, FENC is in line with its industry, outperforming 54.10% of the companies in the same industry.
- A Quick Ratio of 4.44 indicates that FENC has no problem at all paying its short term obligations.
- FENC has a Quick ratio of 4.44. This is comparable to the rest of the industry: FENC outperforms 52.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.69 | ||
| Quick Ratio | 4.44 |
3. Growth
3.1 Past
- The earnings per share for FENC have decreased strongly by -475.00% in the last year.
- Looking at the last year, FENC shows a very negative growth in Revenue. The Revenue has decreased by -21.39% in the last year.
EPS 1Y (TTM)-475%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.48%
Revenue 1Y (TTM)-21.39%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%78.69%
3.2 Future
- FENC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 240523.00% yearly.
- The Revenue is expected to grow by 24.44% on average over the next years. This is a very strong growth
EPS Next Y-248058267475566850%
EPS Next 2Y10558111022.08%
EPS Next 3Y26458100%
EPS Next 5Y240523%
Revenue Next Year-20.03%
Revenue Next 2Y16.86%
Revenue Next 3Y19.53%
Revenue Next 5Y24.44%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- FENC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- A Price/Forward Earnings ratio of 12.64 indicates a correct valuation of FENC.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of FENC indicates a rather cheap valuation: FENC is cheaper than 97.52% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 25.95. FENC is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 12.64 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as FENC's earnings are expected to grow with 26458100.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10558111022.08%
EPS Next 3Y26458100%
5. Dividend
5.1 Amount
- FENC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FENNEC PHARMACEUTICALS INC / FENC FAQ
What is the fundamental rating for FENC stock?
ChartMill assigns a fundamental rating of 3 / 10 to FENC.
Can you provide the valuation status for FENNEC PHARMACEUTICALS INC?
ChartMill assigns a valuation rating of 3 / 10 to FENNEC PHARMACEUTICALS INC (FENC). This can be considered as Overvalued.
What is the profitability of FENC stock?
FENNEC PHARMACEUTICALS INC (FENC) has a profitability rating of 2 / 10.
What is the financial health of FENNEC PHARMACEUTICALS INC (FENC) stock?
The financial health rating of FENNEC PHARMACEUTICALS INC (FENC) is 3 / 10.
What is the earnings growth outlook for FENNEC PHARMACEUTICALS INC?
The Earnings per Share (EPS) of FENNEC PHARMACEUTICALS INC (FENC) is expected to decline by -248058267475566850% in the next year.